Indoco Remedies Goa Plant successfully clears Malta Medicines Authority audit

Indoco Remedies Ltd. has announced today that the Malta Medicines Authority had inspected the Company's manufacturing facility for solid oral dosage form (Plant I) located at Goa, from November 19 - November 24, 2025.

The facility has received EU GMP certification from the Malta Medicines Authority confirming that it complies with the Good Manufacturing Practice requirements as referred in the EC Directive.

Commenting on this development, Ms. Aditi Panandikar, Managing Director - Indoco Remedies Ltd. said, "Compliance is a core value that drives our quality systems. This approval reinforces our commitment to delivering highest quality healthcare to our customers worldwide.:

Shares of Indoco Remedies Limited was last trading in BSE at Rs. 231.05 as compared to the previous close of Rs. 237.20. The total number of shares traded during the day was 8818 in over 242 trades.

The stock hit an intraday high of Rs. 240.20 and intraday low of 230.45. The net turnover during the day was Rs. 2066772.00.

Source : Equity Bulls

Keywords

IndocoRemedies INE873D01024 Pharmaceuticals MaltaMedicinesAuthroity Audit GoaPlant